Pharmaceuticals, Biotechnology and Life Sciences
The development of the UK’s first dedicated Vaccines Manufacturing Innovation Centre (VMIC) has moved a step closer with the contract to design an advanced array of laboratory and production facilities within a ‘cleanroom wrap’ environment being awarded to WHP, the company has said in a statement.
Published in the journal Vaccine, data show vaccines targeting theH10N8 and H7N9 influenza viruses to be highly immunogenic andwell-tolerated in healthy adults
The global influenza vaccines market size is expected to surpass USD 6billion by 2025.
DUBLIN–(BUSINESS WIRE)–The “Global Preventive Vaccines Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added to ResearchAndMarkets.com’s…
Sanofi is investing €350 million for the construction of a new vaccine manufacturing facility at the Sanofi Pasteur Canadian headquarters…
Global Vaccines Market to reach US$ 60 Billion by the year 2022. Pediatric vaccines market is having a dominant market share compared…
Valneva has given Merck in United States and Canada rights to use its EB66 technology to research new veterinary vaccines.
Pfizer Inc. has announced that it has completed the acquisition of GlaxoSmithKline’s quadrivalent meningococcal ACWY vaccines Nimenrix and Mencevax.